Lactams

Medchemexpress LLC 5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 26166-92-7 | MFCD30188073 | 97.0% | 337.13 | C13H9BrN2O4 | 25 MG

Thalidomide-5-Br (5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione) is a brominated thalidomide derivative supplied as a research reagent and used in studies of inflammation, tumor biology, and neurology.

• contains a brominated thalidomide core
• used in inflammation research
• applicable to tumor biology studies
• suitable for neurology research
• available in small research quantities

Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 96.7% | 337.13 g/mol | C13H9BrN2O4 | 5 MG

Thalidomide-4-Br is a brominated derivative of thalidomide supplied as a solid research reagent. It is active against bromodomains and is used in preclinical research on inflammation, tumor biology, and neurology. The compound is provided in small milligram quantities for screening, biochemical assays, and exploratory studies.

• Brominated thalidomide derivative with defined activity toward bromodomains.
• High purity suitable for biochemical and cellular research.
• Available in small-quantity packs for early-stage studies.
• Stable solid form with recommended cold storage for long-term retention.
• Documented chemical identifiers, including CAS and molecular formula, for traceability.

Medchemexpress LLC Thalidomide-5-br | 26166-92-7 | MFCD30188073 | 98.4% | 337.13 | C13H9BrN2O4 | 5 MG

Thalidomide-5-Br is a brominated derivative of thalidomide provided for research use. It is described as a compound with a bromodomain and is used in preclinical studies of inflammation, tumor biology, and neurology.

• Used in research related to inflammation, tumor biology, and neurology.
• High purity suitable for biochemical assays and medicinal chemistry.
• Available in small milligram quantities for discovery studies.
• Stable at room temperature for extended storage under recommended conditions.
• Contains a bromodomain-containing structure for target engagement studies.

Medchemexpress LLC Thalidomide-5-Br | 26166-92-7 | 98.4% | 337.13 g/mol | C13H9BrN2O4 | 50 MG

Thalidomide-5-Br is a brominated thalidomide analogue supplied for biochemical research. It has a reported molecular weight of 337.13 g/mol and is supplied as an off-white to gray solid with reported purity around 98%.

• Used in research of inflammation, tumor biology, and neurology.
• Supplied as a solid suitable for formulation or dissolution in solvent for experimental use.
• Reported high purity for analytical and preclinical studies.
• Stable at room temperature for extended storage; in-solution storage requires low temperatures.

Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 99.7% | 337.13 g·mol⁻¹ | C13H9BrN2O4 | 10 MG

Thalidomide-4-Br is a brominated derivative of thalidomide that acts as a small-molecule bromodomain probe. It is provided as a high-purity solid for in vitro and preclinical research in inflammation, oncology, and neurology.

• Bromodomain-containing small molecule probe.
• Suitable for inflammation, tumor, and neurology research.
• High purity: 99.7%.
• Molecular formula C13H9BrN2O4; molecular weight 337.13 g·mol⁻¹.
• Available in multiple pack sizes including 10 mg.
• Powder storage: -20°C (3 years) or 4°C (2 years).

Medchemexpress LLC 5-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 26166-92-7 | MFCD30188073 | 98.4% | 337.13 | C13H9BrN2O4 | 100 MG

Thalidomide-5-Br is a brominated thalidomide derivative supplied for research use in studies of inflammation, tumor biology, and neurology. It is provided as a solid research reagent; consult lot-specific documentation for analytical details.

• Contains a bromodomain; used as a tool compound in biochemical and pharmacological research.
• Reported purity approximately 98% (see product documentation for lot-specific certificate of analysis).
• Solid, off-white to gray appearance suitable for analytical and synthetic applications.
• Storage recommendations: room temperature for shipping; in solution store at -80°C (2 years) or -20°C (1 year).
• Available in multiple pack sizes including 100 mg.

Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 99.6% | 337.13 g·mol⁻¹ | C13H9BrN2O4 | 200 MG

Thalidomide-4-Br is a brominated thalidomide derivative used as a research compound that engages bromodomains and cereblon-related E3 ligase biology. It is applied in studies of inflammation, tumor biology, and neurology and is supplied as a high-purity solid with recommended cold storage for powder and solutions.

• Engages bromodomains and E3 ligase pathways.
• Used in inflammation, tumor, and neurology research.
• Reported purity approximately 99.6% (COA/product listings).
• Solid, off-white to gray physical form.
• Storage: powder at -20°C (long term) or 4°C (short term); solutions at -80°C or -20°C.
• Available in small-scale amounts and DMSO solution formats.

Medchemexpress LLC 4-bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione | 2093536-12-8 | 99.6% | 337.13 g/mol | C13H9BrN2O4 | 100 MG

Thalidomide-4-Br is a brominated thalidomide analog used as a research reagent and cereblon/E3 ligase ligand. It is employed in PROTAC development and in studies of inflammation, tumor biology, and neurology. The compound is supplied as a solid with high reported purity and should be stored cold according to handling recommendations.

• Useful as an E3 ligase and cereblon ligand in PROTAC design and degradation studies.
• Applicable to research in inflammation, tumor biology, and neurology.
• Provided as an off-white to gray solid in multiple pack sizes suitable for screening and synthesis.
• High reported purity (99.6%).
• Stable when stored cold; follow recommended powder and solvent storage conditions.
• Available in solution format for screening, for example 10 mM in DMSO.

Medchemexpress LLC Thalidomide-4-Br | 2093536-12-8 | MFCD31730866 | 99.6% | 337.13 | C13H9BrN2O4 | 50 MG

Thalidomide-4-Br is a brominated thalidomide derivative used as a cereblon/bromodomain ligand in preclinical research on inflammation, oncology, and neurology. It is supplied as a solid, off-white to gray powder with characterized identity and stability data.

• High purity (reported ≈99.6%).
• Well characterized: CAS 2093536-12-8; formula C13H9BrN2O4; molecular weight 337.13.
• Available in multiple package sizes, including small (50 mg) and larger quantities.
• Defined storage and stability: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).
• Suitable for cereblon-targeting studies and use as a ligand in PROTAC development.